证券代码：301305 证券简称：朗坤科技 公告编号：2025-069 深圳市朗坤科技股份有限公司 2025年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或者重大遗漏。 特别提示: 2、网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 9 月 11 日 的交易时间，即 9:15-9:25，9:30-11:30 和 13:00-15:00； 通过深圳证券交易所互联网投票系统进行网络投票的具体时间为：2025 年 9 月 11 日 9:15-15:00 期间的任意时间。 3、会议召开地点：深圳市龙岗区坪地街道高桥社区坪桥路 2 号朗坤科技园公 司会议室 4、会议的召开方式：现场表决与网络投票相结合的方式 5、会议召集人：深圳市朗坤科技股份有限公司（以下简称"公司"）董事会 6、会议主持人：公司董事长陈建湘先生 1、本次股东会无变更、否决提案的情形； 2、本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开情况 1、现场会议召开时间：2025年9月11日（星期四）下午15:00 7、本次股东会的召集和召开符合《中 ...

2025 年半年度跟踪报告 | 保荐人名称：招商证券股份有限公司 | 被保荐公司简称：朗坤科技 | | --- | --- | | 保荐代表人姓名：王玉亭 | 联系电话：0755-82943234 | | 保荐代表人姓名：刘畅 | 联系电话：0755-82960330 | 招商证券股份有限公司 关于深圳市朗坤科技股份有限公司 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1.公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 0次 | | 2.督导公司建立健全并有效执行规章制度的情况 | | | （1）是否督导公司建立健全规章制度（包括但不限于防止关 联方占用公司资源的制度、募集资金管理制度、内控制度、内 | 是 | | 部审计制度、关联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3.募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 6次 | | （2）公司募集资金项目进展是否与信息披露文件一致 | 是 | | 4.公司治理督导情况 | | | （1）列 ...

Market Performance - The environmental governance sector rose by 0.97% on September 11, with Fu Jie Environmental leading the gains [1] - The Shanghai Composite Index closed at 3875.31, up 1.65%, while the Shenzhen Component Index closed at 12979.89, up 3.36% [1] Top Gainers in Environmental Governance - Fu Jie Environmental (688335) closed at 17.47, with a significant increase of 19.99% and a trading volume of 133,100 shares, amounting to 222 million yuan [1] - China Tianrong (000035) saw a rise of 9.92%, closing at 5.21 with a trading volume of 1,044,400 shares, totaling 531 million yuan [1] - Zhenghe Ecology (605069) increased by 6.60%, closing at 11.46 with a trading volume of 285,400 shares, amounting to 331 million yuan [1] Decliners in Environmental Governance - Green Yin Ecology (002887) decreased by 2.49%, closing at 9.79 with a trading volume of 112,700 shares, totaling 110 million yuan [2] - Qiaoyin Co. (002973) fell by 2.40%, closing at 15.03 with a trading volume of 77,500 shares, amounting to 116 million yuan [2] - Feinan Resources (301500) dropped by 1.40%, closing at 17.65 with a trading volume of 162,300 shares, totaling 28.5 million yuan [2] Capital Flow Analysis - The environmental governance sector experienced a net outflow of 397 million yuan from institutional investors, while retail investors saw a net inflow of 533 million yuan [2][3] - Major stocks like China Tianrong and Yuanda Environmental had mixed capital flows, with China Tianrong seeing a net inflow of 106 million yuan from institutional investors [3]

责任编辑：小浪快报 第2笔成交价格为22.03元，成交30.00万股，成交金额660.90万元，溢价率为-0.81%，买方营业部为机构 专用，卖方营业部为中银国际证券股份有限公司广东分公司。 进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为991.35万元。该股近5个交易日累 计上涨10.33%，主力资金合计净流入2825.96万元。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 9月10日，朗坤科技收跌0.54%，收盘价为22.21元，发生2笔大宗交易，合计成交量45万股，成交金额 991.35万元。 第1笔成交价格为22.03元，成交15.00万股，成交金额330.45万元，溢价率为-0.81%，买方营业部为机构 专用，卖方营业部为中泰证券股份有限公司广东分公司。 ...

每经AI快讯，有投资者在投资者互动平台提问：请问公司HMO母乳低聚糖是否已实现出口销售，产品 生产、销售、研发情况如何？ 朗坤科技（301305.SZ）9月8日在投资者互动平台表示，目前朗健生物一期年产260 吨项目已进入试生 产阶段，各项生产环节正稳步推进。公司多种生产菌株申报国家卫健委审批已获受理，同时已与主要目 标客户建立联系，进入部分头部乳制品企业合格供应商引入环节，后续将持续发力市场拓展。 （文章来源：每日经济新闻） ...

Core Viewpoint - The company reported a slight decline in revenue but a significant increase in net profit, driven by improvements in core business efficiency [2][3] Revenue and Profit Performance - In the first half of 2025, the company achieved operating revenue of 855 million yuan, a year-on-year decrease of 4%, while net profit attributable to shareholders reached 147 million yuan, a year-on-year increase of 22% [1][2] - The net profit after deducting non-recurring items was 145 million yuan, reflecting a year-on-year growth of 25.43% [2] Business Segment Analysis - The bioenergy (biodiesel) segment was a key driver of profit growth, generating revenue of 474 million yuan, up 6.38% year-on-year, with a significant reduction in operating costs by 7.22%, leading to a gross margin increase of 9.71 percentage points to 33.77% [2][3] - The traditional biomass waste operation service business also showed steady growth, achieving revenue of 314 million yuan, a year-on-year increase of 12.11% [3] Synthetic Biology Business Development - The synthetic biology manufacturing business made significant progress, with LNT and LNnT products receiving Self-GRAS certification in the U.S., paving the way for market expansion [4] - The company has completed fermentation production of 30 tons of LNnT and is advancing the development of various HMO products [4] Future Earnings Forecast - The company is projected to achieve operating revenues of 2.293 billion, 2.882 billion, and 3.625 billion yuan for 2025-2027, with year-on-year growth rates of 28.03%, 25.68%, and 25.81% respectively [5] - Net profit attributable to shareholders is expected to be 302 million, 405 million, and 519 million yuan for the same period, with growth rates of 40.07%, 34.12%, and 28.19% respectively [5]

风险提示：投资有风险，市场波动可能导致股价变动，请谨慎决策。 消息面上，朗坤科技在互动平台表示，公司持续聚焦主营业务发展，通过优化业务结构、提升经营效率 等措施，力求为股东创造可持续回报。 资金方面，8月26日主力资金净流出79.10万元，但近五日主力资金整体呈现净流入状态，累计净流入 2741.51万元。 截至2025年8月26日收盘，朗坤科技股价报20.63元，较前一交易日下跌0.24%，成交额1.91亿元。 朗坤科技主营业务涵盖生物质资源再生和合成生物智造两大领域。公司2025年半年报显示，上半年实现 归母净利润1.47亿元，同比增长22.36%，并拟向全体股东每10股派现2元。此外，公司经营活动现金流 净额为2.01亿元，资产负债结构保持稳健。 ...

Core Viewpoint - Longkun Technology (301305) is committed to focusing on its core business development and aims to enhance long-term value for shareholders through various measures [1] Group 1 - The company is enhancing operational efficiency and optimizing its business structure [1] - Strengthening compliance governance is a key initiative for the company [1] - The company emphasizes effective communication with investors to support its objectives [1]

Core Insights - The company reported a total revenue of 855 million yuan for the first half of 2025, a decrease of 38.48 million yuan compared to the same period last year, representing a year-on-year decline of 4.31% [1] - The net profit attributable to shareholders was 147 million yuan, with net cash inflow from operating activities amounting to 201 million yuan, which is a decrease of 40.99 million yuan, reflecting a year-on-year decline of 16.91% [1] Financial Metrics - The latest debt-to-asset ratio stands at 36.28% [3] - The gross profit margin is reported at 35.84%, down by 2.64 percentage points from the previous quarter [3] - The return on equity (ROE) is 3.95% [3] - The diluted earnings per share (EPS) is 0.61 yuan [3] - The total asset turnover ratio remained stable compared to the same period last year, with a year-on-year decline of 1.11% [3] - The inventory turnover ratio is 7.55 times [3] Shareholder Structure - The number of shareholders is 21,200, with the top ten shareholders holding a total of 124 million shares, accounting for 51.23% of the total share capital [3] - The largest shareholder is Shenzhen Jianyin Wealth Investment Holding Co., Ltd., with a holding ratio of 11.94% [3] - Other significant shareholders include Chen Jianxiang (6.44%), Zhang Liyin (6.34%), and Shenzhen Langkun Investment Partnership (5.96%) [3]

2025年8月26日，朗坤科技(301305.SZ)发布2025年半年度报告。截至2025年8月25日，共有10个机构投 资者披露持有朗坤科技A股股份，合计持股量达7368.01万股，占朗坤科技总股本的30.54%。其中，前 十大机构投资者包括深圳市建银财富投资控股有限公司、深圳市朗坤投资合伙企业(有限合伙)、共青城 朗坤投资管理合伙企业(有限合伙)、贵州享硕股权投资合伙企业(有限合伙)、深圳华迪光大股权投资基 金(有限合伙)、广州盛隆投资合伙企业(有限合伙)、海通创新证券投资有限公司、万联广生投资有限公 司、广州六脉资江股权投资合伙企业(有限合伙)、广东毅达创新创业投资合伙企业(有限合伙)，前十大 机构投资者合计持股比例达30.54%。相较于上一季度，前十大机构持股比例合计下跌了1.94个百分点。 公募基金方面，本期较上一季未再披露的公募基金共计1个，即兴银国证新能源车电池ETF。 ...